In this study, we combined immunohistochemical, morphological, and biochemical approaches to understand whether the cell-autonomous reduction of CYFIP2 in excitatory pyramidal neurons is sufficient to induce AD-like pathologies in the hippocampal CA1 region. The gene discussed is CYFIP2; the disease is Alzheimer disease.